Blood Coagulants Market of ME&A Segment to Reach CAGR of 9.5% by 2023 with key vendors: Shire, SOBI, Octapharma, and CSL Limited, Pfizer Inc., Bayer AG, Novo Nordisk AS

Blood Coagulant Market is expected to grow at the CAGR of 9.5% during the forecast period 2017-2023. As per a study published in Blood Coagulation Fibrinolysis journal in 2016, Yaoundé Hemophilia Treatment Center (HTC) of Cameroon multiple cases of hemophilia and von willebrand disease (VWD) were registered.      

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/2743 . 

Blood Coagulant Market of Middle East & Africa’s growth is majorly attributed to increasing prevalence of the bleeding disorders, rising funding, healthcare insurance coverage, and awareness programs for bleeding disorders. Coagulation is the procedure through which blood changes from a fluid to a gel, framing a blood coagulation. Coagulation also reffered as clotting. It is a natural process occurs to heal a lesion/wound/cut and stop the bleeding. In the Middle East and Sub-Saharan Africa, bleeding disorders have become a huge problem due to limited screening, ignorance of diseases, and poor access to treatment.

According to the Annual Global Survey of World Federation of Hemophilia (WFH), in 2014 the total population of Egypt was 86,895,099 out of which 5,246 people were living with hemophilia, 513 were living with von willebrand disease, and 1,123 had bleeding disorders. It is also reported that 4201 cases of hemophilia A were registered and among them 37% patients were under 4 years. A research study published in Medicine journal in 2017 stated that hemophilia A is the most common type of hemophilia in Saudi Arabia and dominant in male: 1: 5000 to 10,000. Whereas, prevalence rate of hemophilia B: 1: 34,500 male patients.

Market Segments:  

On the basis of drug class which comprises of coagulation factor which is further sub-segmented into plasma derived and recombinant coagulation factor; vitamin K analogues, fibrinogen analogues and others.  UAE is the largest market for blood coagulant drugs in Middle East and Africa’s market of blood coagulating drugs closely followed by Egypt. Middle East and Africa blood coagulants market has been segmented. clinical indications; market is segmented into accidents, surgery, hemophilia and others. 

Key Findings:

MEA blood coagulants market for hemophilia segment was estimated to be USD31.55 million in 2016

UAE is the fastest growing region in the MEA market and projected to grow at a CAGR of 10.1% during forecast period

Hemophilia segment dominates the market with nearly 45.5% share of the MEA market

MEA blood coagulation market is projected to reach about USD141.68 million by 2023

Excess Full Report @ https://www.marketresearchfuture.com/reports/blood-coagulants-market-2743 .

Regional Analysis of Middle East and Africa Blood Coagulants Market:  

Another market that has witnessed good growth rates is Saudi Arabia, because of the greater expenditure on health by the local government and the rise in per capita income of the people. Noteworthy markets in Africa include South Africa and Algeria. The demand for these products have given rise to many biotechnological firms especially in India. The rest of Africa market is however the fastest growing with a huge unmet medical needs.

The market for blood coagulants favors organizations with solid innovative research and hello there tech in-house abilities. The market mirrors an oligopolistic nature with a couple of players ruling the market.

Study Aims Middle East and Africa Blood Coagulants Market:

To provide detail analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the Middle East and Africa blood coagulants market. Insights about factors affecting the market growth

Overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

Track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments globally. Important people for the market of blood coagulants Blood coagulants are manufacturers, Blood coagulants suppliers, Private research laboratories, Research and development (R&D) companies, Market research and consulting service providers, Government research laboratories, Contract manufacturing organizations

Huge Companies Participated for Middle East and Africa Blood Coagulants Market: Shire (Republic of Ireland), SOBI (Sweden), Octapharma (Switzerland), and CSL Limited (Australia), Pfizer Inc. (U.S.), Bayer AG (Germany), Novo Nordisk AS (Dernmark).

List of Tables:
Table 1 Middle East & Africa Blood Coagulants Market By Type, 2014 To 2023 (USD Million) 20
Table 2 Middle East & Africa Coagulation Factor Market By Type, 2014 To 2023 (USD Million) 21
Table 3 Middle East & Africa Coagulation Factor Market By Countries, 2014 To 2023 (USD Million) 22
Table 4 Middle East & Africa Recombinant Coagulation Factor Market By Countries,
2014 To 2023 (USD Million) 23
Table 5 Middle East & Africa Plasma Derived Coagulation Factor Market By Countries,
2014 To 2023 (USD Million) 24
Table 6 Middle East & Africa Blood Coagulants Market By Indication, 2014 To 2023 (USD Million) 26
Table 7 Middle East & Africa Blood Coagulants Market For Haemophilia By Country,
2014 To 2023 (USD Million) 27
Table 8 Middle East & Africa Blood Coagulants Market For Surgery By Country,
2014 To 2023 (USD Million) 28
Table 9 Middle East & Africa Blood Coagulants Market For Other Bleeding Disorders By Country,
2014 To 2023 (USD Million) 29
Table 10 Middle East & Africa Blood Coagulants Market, By Country, 2014 To 2023 (USD Million) 31
Table 11 Saudi Arabia Blood Coagulants Market By Type, 2014 To 2023 (USD Million) 32
Table 12 Saudi Arabia Coagulation Factor Market By Type, 2014 To 2023 (USD Million) 32
Table 13 Saudi Arabia Blood Coagulants Market By Indication, 2014 To 2023 (USD Million) 33
Table 14 United Arab Emirates Blood Coagulants Market By Type, 2014 To 2023 (USD Million) 34
Table 15 United Arab Emirates Coagulation Factor Market By Type, 2014 To 2023 (USD Million) 34
Table 16 United Arab Emirates Blood Coagulants Market By Indication, 2014 To 2023 (USD Million) 35
Table 17 Qatar Blood Coagulants Market By Type, 2014 To 2023 (USD Million) 36
Table 18 Qatar Coagulation Factor Market By Type, 2014 To 2023 (USD Million) 36

Get Discount for this Report @ https://www.marketresearchfuture.com/check-discount/2743 .

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.